Skip to Main Content

Latest News

  • Yale Urology Faculty Profile: Mary Grey Maher, MD

    This month we highlight Mary Grey Maher, MD, Associate Professor of Clinical Urology. Dr. Maher talks about how the field of urology has diversified, the impact of mentors, and advice she would share with anyone pursuing a career in medicine–in her own words.

    Read more
  • Westerly Hospital introduces state-of-the-art imaging system for enhanced prostate biopsies

    Westerly Hospital is the first hospital in New England to use a state-of-the-art micro-ultrasound device that more precisely visualizes prostate tumors for patients undergoing prostate-specific antigen (PSA) screening and prostate biopsies. The new system allows for real-time, high-resolution imaging that guides the surgeon during the biopsy and produces images that allow the urologist to better distinguish cancerous tissue from normal tissue, which can enhance the quality of the biopsy.

    Read more
  • Wilton PD kicks off ‘No-Shave November’ to highlight men’s health issues

    Wilton police will be participating in an expanded “No-Shave November” until January by growing out their facial hair to highlight men’s health issues.No Shave November events are traditionally associated with prostate and testicular cancer. Dr. Stanton Honig, the chief of men's health at Yale Medicine, says many men's health problems can be easily solved if they're caught early, "One of the nice things about men's cancers is when they're found early, especially testicular cancer it's got a 99 percent cure rate."

    Source: News12 Connecticut
    Read more
  • Urologic practice consolidation by private equity firms

    In the recent years, private equity firms have acquired many urology practices. Although this is common in other specialties, there is little known about these acquisitions in the field of urology. A recent Urology Practice study, led by Michael S. Leapman, MD, sought to investigate the trends in sudden and significant private equity acquisitions among urology practices between 2011 and 2021.

    Source: Urology Times
    Read more
  • Yale Urology Faculty Profile: Meet Dr. Thomas V. Martin

    Our first feature highlights Thomas V. Martin, MD, Associate Professor of Clinical Urology, who has been a member of Yale Urology faculty since 2013. Dr. Martin talks about his time as a Yale Urology resident and the impact it had on his career, about his role as Chair of the Clinical Operations committee, and how much the field of urology has changed in the 25 years since he was a resident–in his own words.

    Read more
  • Rucaparib/nivolumab combo shows clinical activity in HRD-positive mCRPC

    Combination therapy with the PARP inhibitor rucaparib (Rubraca) and the immunotherapy nivolumab (Opdivo) demonstrated clinical activity in patients with homologous recombination deficiency–positive metastatic castration-resistant prostate cancer (mCRPC) who had no prior chemotherapy, according to findings shared during the 2021 ESMO Congress.

    Source: Urology Times
    Read more
  • Meet Kathy, Kidney and Bladder Cancer Survivor

    My first encounter with cancer was in October 2008 when I was diagnosed with kidney cancer and needed to have my right kidney removed. A few years passed, and I thought I was done with cancer; unfortunately, I was wrong.

    Read more